Vladislav Derkach

Mr. Vladislav Derkach

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2025 in Gels
Verified
Journal Article
Open access
PDF file
Natalia MenshutinaNatalia Menshutina
Natalia Menshutina
Vladislav DerkachVladislav Derkach
Vladislav Derkach
EMElizaveta Mokhova
Elizaveta Mokhova
MGMariia Gordienko
Mariia Gordienko
This article presents the results of a study on the rheological characteristics of in situ thermosensitive nasal gels based on poloxamer 407 (P407) and their effect on spray angle. The development of new drug delivery systems based on in situ thermosensitive gels can overcome several shortcomings of traditional nasal sprays associated with mucociliary clearance and low mucoadhesion. Using the cold method, samples based on P407 were prepared in pure form, in combination with poloxamer 188 (P188), and with the addition of several mucoadhesive polymers: chitosan, sodium alginate, and hydroxypropyl methylcellulose (HPMC). Analytical studies were carried out for all obtained samples, which showed that the gelling temperature (Tsol–gel) of compositions with P407 was inversely dependent on its concentration, decreasing from 32.71 °C to 24.63 °C. The addition of hydrophilic P188 increased Tsol–gel. The addition of mucoadhesive polymers had varying effects on Tsol–gel: chitosan and HPMC increased the temperature, while sodium alginate decreased it. The addition of mucoadhesive polymers significantly affected the viscosity of the formulations; for example, the addition of sodium alginate resulted in a fivefold increase, making the formulations unsuitable for spraying. A study of the spray angles of Tsol–gel samples in the range of 27–31 °C using the SprayVIEW measuring system revealed an inverse relationship between the viscosity of the formulations and the spray angle. A mathematical model of the solution droplet trajectory was presented, enabling the spray angle to be predicted depending on the formulation composition. The relative error of the computational experiments did not exceed 10%. This approach has the potential to reduce the number of full-scale experiments, and consequently their cost.

20 December 2025 in Problems of Biological, Medical and Pharmaceutical Chemistry
Verified
Journal Article
Closed access
AUAnastasia Uvarova
Anastasia Uvarova
Vladislav DerkachVladislav Derkach
Vladislav Derkach
MKM. Klimenko
M. Klimenko
MGMariia Gordienko
Mariia Gordienko
Introduction. Vinpocetine has neuroprotective properties and is used to improve cognitive function; however, poor solubility and low bioavailability may limit its use. The development of a dry nasal spray vinpocetine with increased solubility is a topical issue. Aim of the study was to develop the composition of a prototype dry nasal spray of vinpocetine and the technology for its production. Material and Methods. The prototypes contained chitosan and synthesized poly-β-cyclodextrin. The formation of host-guest inclusion complexes by co-dissolution and co-attrition methods increased vinpocetine solubility. IR spectroscopy and X-ray diffraction analysis were used to confirm the formation of inclusion complexes and evaluate the sample properties. Spray drying was the final step in the formation of the dry nasal spray. The stability and mass (volume) uniformity of doses taken from a multi-dose package, dosing in a dry powder dispenser, and in vitro permeability in a transdermal diffusion tester were studied for the lead formulation. Results. Comparative studies of the developed samples with different vinpocetine:polycyclodextrin ratios were conducted. No significant differences in inclusion complex formation were demonstrated by the two methods. Therefore, the co-dissolution method was chosen as the preferred method for producing dry nasal spray prototype samples, as it is technologically simpler. In vitro permeation results showed that most of the vinpocetine dissolves and penetrates the membrane within 30 minutes. Dosage uniformity and stability of the developed prototypes for 12 months were demonstrated. Conclusions. The experimental studies demonstrate the feasibility of using powder particles containing the vinpocetine-polycyclodextrin inclusion complex and chitosan, obtained by spray drying, as prototypes for a dry nasal spray for vinpocetine.

20 December 2025 in Problems of Biological, Medical and Pharmaceutical Chemistry
Verified
Journal Article
Closed access
Vladislav DerkachVladislav Derkach
Vladislav Derkach
MGMariia Gordienko
Mariia Gordienko
Introduction. Favipiravir is a selective inhibitor of viral RNA polymerase with a broad spectrum of antiviral activity; however, its low aqueous solubility results in reduced oral bioavailability. Therefore, the development of new delivery systems, such as thermosensitive nasal in situ gels, is necessary. The purpose of the work. To develop and characterize thermosensitive in situ gels based on P407 and P188 for intranasal delivery. Material and methods. Favipiravir-loaded PLGA nanoparticles were prepared using nanoprecipitation. Particle diameter was determined using dy-namic light scattering (DLS) at 25 °C. Thermosensitive gels were prepared using the cold method with varying P407 concentrations and varying the P407/P188 ratio. Rheological properties were measured using a SmartPave 102 rheometer at 10–40 °C and a heating rate of 0.05 °C/sec. In vitro re-lease studies were conducted using a DHC-6T transdermal diffusion tester in phosphate buffer, pH 6.4, at 37 °C, with samples analyzed at six time points using UV spectrophotometry. Results. The average diameter of favipiravir-loaded PLGA nanoparticles was 168.14±3.49 nm, a suitable size for intranasal delivery via the nose-to-brain mechanism. In situ temperature-sensitive gel studies revealed that as the P407 concentration increased from 18 to 25% by weight, the Tsol-gel decreased from 29.04±0.63 °C to 21.84±0.19 °C. The addition of P188 at an 8/2 ratio (P407/P188) significantly increased the T in the sol-gel by 6.64–8.38 °C compared to systems without P188. The favipiravir release profile from the API suspension was characterized by rapid release (46% in 5 min, 72% in 10 min); from PLGA nanoparticles, by delayed release (17–29% in 5–10 min, 94% in 120 min); and from the in situ gel with nanoparticles, by the most prolonged release (3–9% in 5–10 min, 65% in 120 min). Conclusion. An intranasal delivery system consisting of PLGA nanoparticles loaded with favipiravir in a thermosensitive in situ gel matrix based on P407 and P188 was developed. A dual release control mechanism (polymer degradation and delayed diffusion from the gel matrix) provides a pro-nounced prolonged effect.